Passage Bio, Inc.
PASG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $25 | $22 | $35 |
| - Cash | $53 | $58 | $63 | $38 |
| + Debt | $21 | $25 | $25 | $25 |
| Enterprise Value | – | -$8 | -$16 | $23 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$9 | -$14 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$9 | -$15 | -$13 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.45 | -2.96 | -4.96 | -4.1 |
| % Growth | 17.2% | 40.3% | -21% | – |
| Operating Cash Flow | -$5 | -$6 | -$14 | -$8 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$5 | -$6 | -$14 | -$8 |